Skip to main navigation Skip to search Skip to main content

Microalbuminuria in inflammatory bowel disease

  • N Mahmud
  • , J Stinson
  • , M A O'Connell
  • , T J Mantle
  • , P W Keeling
  • , J Feely
  • , D G Weir
  • , D Kelleher

    Research output: Contribution to journalArticlepeer-review

    62 Citations (Scopus)

    Abstract

    Microalbuminuria independently predicts the development of nephropathy and increased cardiovascular morbidity and mortality in diabetic patients, but it may be an indicator of the acute phase response. This study examined microalbuminuria as a marker of the acute phase response in patients with inflammatory bowel disease and correlated it with the disease activity in 95 patients with inflammatory bowel disease (ulcerative colitis (n = 52), Crohn's disease (n = 43)) determined by the simple index of Harvey and Bradshaw. Fifty patients were in complete clinical remission and 45 patients had active disease. Microalbuminuria was detected in all patients with inflammatory bowel disease (147 (17) v 18 (2) microgram/min, inflammatory bowel disease v controls mean (SEM), p
    Original languageEnglish
    Pages (from-to)1599-1604
    Number of pages6
    JournalGut
    Volume35
    Issue number11
    DOIs
    Publication statusPublished - Nov 1994

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • Acute-Phase Reaction
    • Adolescent
    • Adult
    • Aged
    • Albuminuria
    • C-Reactive Protein
    • Chronic Disease
    • Colitis, Ulcerative
    • Crohn Disease
    • Humans
    • Inflammatory Bowel Diseases
    • Middle Aged
    • Prospective Studies
    • Serum Amyloid A Protein

    Cite this